C&C International Co., Ltd. (KOSDAQ:352480)
34,100
-150 (-0.44%)
At close: Feb 6, 2026
C&C International Revenue
C&C International had revenue of 75.36B KRW in the quarter ending September 30, 2025, with 1.67% growth. This brings the company's revenue in the last twelve months to 271.51B, down -6.30% year-over-year. In the year 2024, C&C International had annual revenue of 282.88B with 28.39% growth.
Revenue (ttm)
271.51B
Revenue Growth
-6.30%
P/S Ratio
1.71
Revenue / Employee
450.27M
Employees
603
Market Cap
464.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 282.88B | 62.56B | 28.39% |
| Dec 31, 2023 | 220.33B | 89.72B | 68.70% |
| Dec 31, 2022 | 130.61B | 39.31B | 43.06% |
| Dec 31, 2021 | 91.29B | 1.68B | 1.88% |
| Dec 31, 2020 | 89.61B | 8.01B | 9.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmecca Korea | 590.81B |
| VT Co., Ltd. | 434.59B |
| CLIO Cosmetics Co.,Ltd | 326.53B |
| Englewood Lab | 204.62B |
| Manyo Factory | 118.72B |
| Icure Pharmaceutical Incorporation | 93.22B |
| Genic | 85.47B |
| Coreana Cosmetics | 76.53B |